A fictional 63-year-old presents ten days after systemic anticancer treatment with rigors, new confusion and hypotension. The triage temperature is 37.7°C and the neutrophil count is pending.
Listen for the assumption.
The temperature is below 38°C, so I planned to wait for the neutrophil count before calling this neutropenic sepsis.
Would that threshold protect a confused, hypotensive patient after anticancer treatment?
No. The systemic illness is enough to activate the emergency pathway while we confirm the count and source.
Choose an answer below and reveal the reasoning to see consultant feedback at every checkpoint. The full consultant-led synthesis follows after all three decisions.
Go to the first decision ↓The picture develops.
- Blood pressure remains low after initial assessment
- Central venous access device present
- Neutrophils later return at 0.3 × 10⁹/L
Commit before you reveal.
After you select an option, reveal the model reasoning and the consultant’s feedback.
Hear the senior team refine the plan.
The registrar tests the plan, the consultant synthesises the key principle, and the SHO confirms the safer next steps.
I want the exact treatment dates, regimen, prophylaxis, prior resistant organisms and central-line details in the first handover.
And the time of empiric treatment. Source investigation and critical-care escalation continue without losing the oncology context.
I will document the presentation as an acute medical emergency rather than waiting to relabel it after the blood count.
What must remain explicit.
- Use current local antimicrobial and neutropenic-sepsis guidance.
- Record antibiotic timing and allergy history.
- Escalate shock, hypoxia or altered consciousness immediately.
Where reasoning fails.
- Waiting for a temperature threshold
- Waiting for the neutrophil count
- Using a low-risk score to override instability
Suspected neutropenic sepsis after [treatment and date], with [physiological concerns]. Cultures and empiric treatment were completed at [times]. Count/source status is [summary], and I need urgent oncology/haematology and critical-care review.
Which parts of your current local pathway can be performed in parallel, and who owns each one?